Study summary · research use only
Thermostable hyaluronic acid-based dissolving microneedles with high-loading capacity: design, optimization, and transdermal delivery of anti-aging ingredients
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study (human subjects for skin penetration testing; Bama miniature pig skin for in vitro permeation; UV/D-galactose-induced photoaging mouse model) developed dissolving microneedles delivering 3-O-ethyl ascorbic acid (EAC) and acetyl hexapeptide-8 (AH-8) using a hyaluronic acid/polyvinyl alcohol matrix. Drug loading reached 40% for EAC and 20% for AH-8, with cumulative transdermal delivery of 17.25% for EAC and 11.29% for AH-8, higher than aqueous solutions. In the mouse photoaging model, EAC and AH-8 microneedles were associated with reduced visible signs of aging (wrinkles, skin laxity, erythema), along with reported changes in skin elasticity, hydration, epidermal thickening, and oxidative markers (SOD activity, MDA levels). The authors describe this as a scalable microneedle platform with potential anti-aging applications.
Abstract
This study developed a thermostable, high-loading dissolving microneedle (DMN) system for the transdermal delivery of anti-aging ingredients, 3-O-ethyl ascorbic acid (EAC) and acetyl hexapeptide-8 (AH-8). By using a composite matrix of hyaluronic acid (HA) and polyvinyl alcohol (PVA) in a 3:2 ratio and optimizing a two-step vacuum-assisted micromolding process, we successfully addressed key fabrication challenges, reducing drying time to 2 h and eliminating structural defects. A split-needle design further increased drug loading, reaching 40% for EAC and 20% for AH-8. The resulting DMNs showed excellent mechanical properties, skin penetration efficiency, and biocompatibility in human subjects. In vitro permeation studies using Bama miniature pig skin revealed release profiles influenced by drug-polymer interactions. Despite these differences, both compounds achieved higher cumulative transdermal delivery (EAC: 17.25%; AH-8: 11.29%) than their aqueous solutions. In a UV/D-galactose-induced photoaging mouse model, both EAC-DMNs and AH-8-DMNs significantly reduced visible signs of aging, including wrinkles, skin laxity, and erythema. They also improved skin elasticity and hydration, reversed pathological thickening, and restored oxidative balance by increasing SOD activity and lowering MDA levels. This work provides a scalable, biocompatible, and effective DMN platform, supporting its potential for clinical anti-aging applications.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.